Clinical trial
Efficacy of Early Oseltamivir Phosphate Treatment at Hospital Admission to Reduce Severity of Illness Among Children Aged Less Than 10 Years Hospitalized With Influenza in El Salvador and Panama
NCT01690637 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Early Oseltamivir Phosphate Treatment at Hospital Admission to Reduce Severity of Illness Among Children Aged Less Than 10 Years Hospitalized With Influenza in El Salvador and Panama
- Lead sponsor
- Centers for Disease Control and Prevention
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- September 30, 2012
- Completion date
- November 30, 2013
- Enrollment
- 721 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
human influenza, influenza